Trial Profile
An Open Study to Investigate the Safety and Efficacy of Replenine-VF by Continuous Infusion in Haemophilia B Patients Undergoing Major Surgery.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Factor IX (Primary)
- Indications Haemophilia B
- Focus Therapeutic Use
- Sponsors Bio Products Laboratory
- 07 Oct 2014 New trial record